AusDoc·1 min read
You're in our crosshairs - AHPRA targets doctors embroiled in 'reckless' off-label prescribing
Doctors who prescribe unapproved peptides, medicinal cannabis and GLP-1 weight loss drugs off label could face an investigation without a complaint first being made about their conduct, AHPRA has warned.
The watchdog launched new guidance on Wednesday aimed at tackling “reckless” prescribing off label or for unapproved medicines, especially following brief consultations with patients.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in